ARTICLE | Management Tracks
Dyne names Editas’ Erick Lucera CFO
Plus: Amy Parison to succeed Lucera at Editas, and a new CEO at Akari
March 21, 2025 11:04 PM UTC
CFO Erick Lucera is stepping down at Editas Medicine Inc. (NASDAQ:EDIT) to become CFO of Dyne Therapeutics Inc. (NASDAQ:DYN).
Lucera will join Dyne on March 31 as the company advances late-stage programs for myotonic dystrophy type 1 and Duchenne muscular dystrophy. Before Editas, Lucera was CFO at Aveo Oncology Inc. and Valeritas Inc. Dyne hopes to submit applications next year seeking accelerated approvals of DYNE-101 and DYNE-251...